1. Volume Effect and Retention
The uniform sized hyaluronic acid particles with optimal
viscoelasticity can maintain a long-lasting volume.
2. Safe to Use on Patients
MONALISA is safe to use on patients due to low level
of endotoxin and essentially no BDDE residue.
3. Easy Procedural Operation
The ergonomically-designed rod and grip allow the even distribution of pressure during injection to enable an accurate and safe treatment for both the clinician and the patient.
4. Highly Pure Hyaluronic Acid
GENOSS implements a strict quality control system through direct involvement in the entire production process from the base material of hyaluronic acid to the final product.
5. Global Standard Quality Control
To guarantee the quality of MONALISA, GENOSS strictly fulfills and complies
with the international quality regulations, including KGMP, ISO 13485 and ISO 9001.
Thin-wall needle enables smooth injection which reduces patient’s discomfort during the procedure
30G TW needle for Soft and Mild type
27G TW needle for Hard and Ultra type
27G TW needle for Soft, Mild and Hard type
Ergonomically-designed grips enable an accurate, convenient and safe treatment.
Safe to Use on Patients
The risk of allergic reaction, edema and other adverse side effects were minimized by significantly reducing
the BDDE (chemical agent used to cross-link hyaluronic acid) to the point where it is undetectable.
What is BDDE?
1,4-butanediol diglycidyl ether (BDDE) is a chemical cross-linking agent that produces hyaluronic acid into a gel form.
The BDDE residue should not exceed 2ppm. In the MONALISA, the BDDE residue was undetectable.
Hy-BRID technology enables the production of highly dense and uniform particles in MONALISA.
The volume is maintained for at least 6 months before the dissolution process begins.
Injection of the MONALISA into the treatment site
MONALISA has uniform particle size which yields a volume of natural feel.
MONALISA maintains the same dissolution rate and it is gradually and naturally dissolved and discharged from the body.
Viscoelasticity with the Optimal Ratio
The application of the Hy-BRID technology allows the MONALISA to achieve the ideal
viscoelasticity for greater volume and durability compared to current competitors.
Line up MONALISA
The MONALISA, a hyaluronic acid dermal filler, retains the excellent volume effects for a long time in the initial procedure time and decompose itself naturally over time.
MONALISA Lidocaine Filler
The MONALISA Lidocaine, which contains topical anesthetic lidocaine,
has relieved the discomfort caused by pain during procedure.